Alnylam Pharmaceuticals (ALNY)
Add to Watchlists Create an Alert
27.82
-0.21 -0.75%
NASDAQ
May 22, 4:59PM
BATS Real time
Currency in USD
Alnylam Pharmaceuticals Revenue Quarterly YoY Growth:
-9.45% for March 31, 2013Alnylam Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -9.45% |
| Dec. 31, 2012 | -58.47% |
| Sept. 30, 2012 | -19.39% |
| June 30, 2012 | 1.31% |
| March 31, 2012 | -1.48% |
| Dec. 31, 2011 | -3.48% |
| Sept. 30, 2011 | -24.86% |
| June 30, 2011 | -22.55% |
| March 31, 2011 | -14.93% |
| Dec. 31, 2010 | -20.41% |
| Sept. 30, 2010 | 14.10% |
| June 30, 2010 | 8.19% |
| March 31, 2010 | -1.97% |
| Dec. 31, 2009 | 9.11% |
| Sept. 30, 2009 | -5.77% |
| June 30, 2009 | 3.22% |
| March 31, 2009 | 12.91% |
| Dec. 31, 2008 | 33.85% |
| Sept. 30, 2008 | 57.73% |
| June 30, 2008 | 161.0% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
ALNY Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Targacept | -84.53% |
| Isis Pharmaceuticals | 86.62% |
| ViroPharma | -21.10% |
ALNY Revenue Quarterly YoY Growth Rankings
| Overall |
50th percentile 3996 of 8005 |
| Sector |
40th percentile 409 of 686 in Healthcare |
| Industry |
61st percentile 95 of 248 in Biotechnology |
ALNY Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -58.47% | Dec 2012 |
| Maximum | 161.0% | Jun 2008 |
| Average | 5.93% |
